Flynn James E 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 08:59 am Sale | 2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Flynn James E | 1,781,006 1.900% | -2,697,586 (-60.23%) | Filing |
| 2024-02-01 5:28 pm Purchase | 2024-01-23 | 13G | Edgewise Therapeutics, Inc. EWTX | Flynn James E | 4,478,592 5.250% | 545,455 (+13.87%) | Filing |
| 2023-02-10 10:01 am Unchanged | 2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | Flynn James E | 3,933,137 6.220% | 0 (Unchanged) | Filing |
| 2021-03-30 3:40 pm Purchase | 2021-03-30 | 13G | Edgewise Therapeutics, Inc. EWTX | Flynn James E | 3,933,137 8.270% | 3,933,137 (New Position) | Filing |